Evidence map›Paper›PMID 41562601›Full record

ArticleJournal of intellectual disability research : JIDR2026

COVID-19 Vaccination and Health Outcomes Among Adults With an Intellectual Disability in British Columbia, Canada.

Xibiao Ye, Shengjie Zhang, Marie Paul Nisingizwe, Ioana Sevcenco, Henry Ngo, Alyssa Parker, Yao Nie, Aanu Abayomi, Ross Chilton, Bonnie Henry and 1 more

Abstract read
In one paragraph

Article in Journal of intellectual disability research : JIDR, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Xibiao YeOffice of the Provincial Health Officer, Ministry of Health, lək̓ʷəŋən Territory, Victoria, British Columbia, Canada.
Shengjie ZhangOffice of the Provincial Health Officer, Ministry of Health, lək̓ʷəŋən Territory, Victoria, British Columbia, Canada.
Marie Paul NisingizweOffice of the Provincial Health Officer, Ministry of Health, lək̓ʷəŋən Territory, Victoria, British Columbia, Canada.
Ioana SevcencoOffice of the Provincial Health Officer, Ministry of Health, lək̓ʷəŋən Territory, Victoria, British Columbia, Canada.
Henry NgoOffice of the Provincial Health Officer, Ministry of Health, lək̓ʷəŋən Territory, Victoria, British Columbia, Canada.
Alyssa ParkerOffice of the Provincial Health Officer, Ministry of Health, lək̓ʷəŋən Territory, Victoria, British Columbia, Canada.
Yao NieOffice of the Provincial Health Officer, Ministry of Health, lək̓ʷəŋən Territory, Victoria, British Columbia, Canada.
Aanu AbayomiOffice of the Provincial Health Officer, Ministry of Health, lək̓ʷəŋən Territory, Victoria, British Columbia, Canada.
Ross ChiltonCommunity Living British Columbia, xʷməθkʷəy̓əm (Musqueam), Sḵwx̱wú7mesh (Squamish), and səlilwətaɬ (Tsleil-Waututh) Territories, Vancouver, British Columbia, Canada.
Bonnie HenryOffice of the Provincial Health Officer, Ministry of Health, lək̓ʷəŋən Territory, Victoria, British Columbia, Canada.
Daniele Behn-SmithOffice of the Provincial Health Officer, Ministry of Health, lək̓ʷəŋən Territory, Victoria, British Columbia, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionEarly studies demonstrated a higher risk for SARS-CoV-2 virus infection and severe COVID-19 outcomes such as hospitalisation, intensive care unit admission and death among people with an intellectual disability or other chronic conditions. However, the extent to which COVID-19 vaccination has affected the risk of these outcomes remains unclear.

methodsWe conducted a case-control study to examine the association between vaccination and SARS-CoV-2 virus infection risk in people with an intellectual disability and the general population. COVID-19 cases aged 19 years and older confirmed to be infected between 28 January 2020 and 31 December 2021 were obtained from the British Columbia (BC) COVID-19 Integrated Case List, and up to five controls were selected from the province's healthcare client registry matching on sex, age and residential region. COVID-19 vaccination status was determined using the province's immunisation registry. The Community Living BC (CLBC) Registry of supported adults was linked to identify the intellectual disability status of each case and control. Odds ratios (OR) and 95% confidence intervals (95% CI) were estimated using the conditional logistic regression model. Severe COVID-19 outcomes were ascertained using hospitalisation and death registry databases. Cox regression was used to estimate hazard ratios (HRs) and 95% CIs for the outcomes among COVID-19 cases with and without an intellectual disability. We adjusted for sex, age, residential area and comorbidities.

resultsCLBC-supported adults with an intellectual disability were less likely to contract SARS-CoV-2 virus (OR = 0.66, 95% CI 0.61-0.71), and the protective association was stronger when fully vaccinated (OR = 0.40, 95% CI 0.34-0.48). Once infected, adults with an intellectual disability had a higher risk for COVID-19-associated hospitalisation (HR = 1.96, 95% CI 1.60-2.39), ICU admission (HR = 1.61, 95% CI 1.10-2.36) and death (HR = 1.88, 95% CI 1.15-3.07).

conclusionCOVID-19 vaccination was effective in reducing the risk of SARS-CoV-2 virus infection among people with an intellectual disability. Safety measures such as prioritised vaccination are important steps for protecting vulnerable people with an intellectual disability from SARS-CoV-2 virus infection, especially as COVID-19 cases with an intellectual disability were more likely to suffer severe health outcomes.

Indexed as

COVID-19COVID-19 VaccinesIntellectual DisabilityVaccinationAdultAgedBritish ColumbiaCase-Control StudiesComorbidityFemaleHospitalizationHumansMaleMiddle AgedRegistriesYoung AdultCOVID-19 VaccinesCOVID‐19intellectual disabilitySARS‐CoV‐2 virusvaccination

Identifiers

PMID41562601
PMCPMC12950626

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.